Shui Wang

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

KIAA1429 acts as an oncogenic factor in breast cancer by regulating CDK1 in an N6-methyladenosine-independent manner

Jiayi Qian, Jian Gao, Xi Sun et al. · Oncogene · 2019 · 264 citations

Medicine, Molecular Biology, Oncology +13

Long non-coding RNA NONHSAT101069 promotes epirubicin resistance, migration, and invasion of breast cancer cells through NONHSAT101069/miR-129-5p/Twist1 axis

Na Yao, Yue Fu, Lie Chen et al. · Oncogene · 2019 · 132 citations

Medicine, Molecular Biology, Oncology +17

Circulating microRNAs from the miR-106a–363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer

Minghui Li, Yan Zhou, Tiansong Xia et al. · Breast Cancer Research and Treatment · 2018 · 125 citations · Full text

Medicine, Genetics, Oncology +17

Plasmoid Ejection and Secondary Current Sheet Generation from Magnetic Reconnection in Laser-Plasma Interaction

Quan-Li Dong, Shoujun Wang, Quanming Lu et al. · Physical Review Letters · 2012 · 120 citations · Full text

Natural Sciences, Physics, Electromagnetics +11